Jenny Lam, MD
Transplant Surgery · la Jolla, CANPI 1275915415
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,408 of the $4,616 with a category attached, or 73.8%. 16 manufacturers reported payments, led by Transmedics, Inc. at 47.2% of the total. Reporting peaked in 2023 at $3,405 and has fallen 80.2% since, to $674 in 2025.
Across 51 payments — averaging $90.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Transmedics, Inc.$2K
- Merck$2K
- Madrigal Pharmaceuticals$148
- Takeda Pharmaceuticals U.S.A., Inc.$87
- Phathom Pharmaceuticals, Inc.$61
- Intercept Pharmaceuticals, Inc.$53
- plus $289 from 10 others
What the payments were for
- Travel & lodging$3,40874%
- Food & beverage$1,20826%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Transmedics, Inc. | 2 | $2,180 |
| Merck | 19 | $1,798 |
| Madrigal Pharmaceuticals | 10 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $87 |
| Phathom Pharmaceuticals, Inc. | 3 | $61 |
| Intercept Pharmaceuticals, Inc. | 2 | $53 |
| Lilly USA, LLC | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Sanofi | 1 | $36 |
| Azurity Pharmaceuticals, Inc. | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Veloxis Pharmaceuticals, Inc. | 1 | $24 |
| Orphalan Inc | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Exelixis Inc. | 1 | $17 |
| Eurofins Viracor, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORGAN CARE SYSTEM$2,180
How this compares
$4,616 in reported general payments places this provider in the 70th percentile of 56 transplant surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in la Jolla
- Angeles Baquerizola Jolla$28K
- Jonathan Fisherla Jolla$3K
- Christopher Marshla Jolla$2K
- Dylan Adamsonla Jolla$2K
- Elizabeth SquiersHalf Moon Bay$1.3M
- Myron TongPasadena$99K
- Robert RedfieldOrange$65K
- Yuri GenykLos Angeles$35K
- Navpreet KaurLos Angeles$19K
- Gerald LipshutzLos Angeles$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.